Nabilone for Agitation Blinded Intervention Trial
Nabilone for Agitation Blinded Intervention Trial
Recruiting · NCT04516057 · Registry updated 2026-01-28Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Nabilone for Agitation Blinded Intervention Trial | Alzheimer disease, Chemically-Induced Disorders, Dyskinesias, Neurobehavioral Manifestations, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Psychomotor Agitation, Psychomotor Disorders, Signs and Symptoms, brain disorder, cannabis dependence, central nervous system disorder, cognitive disorder, dementia, nervous system disorder, neurodegenerative disease, psychiatric disorder, substance-related disorder, tauopathy | Recruiting | Phase 3 | 2026-01-28 | NCT04516057 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Alzheimer's Drug Discovery Foundation | 4 |
| Sunnybrook Health Sciences Centre | 193 |
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Centre for Addiction and Mental Health | Toronto | Canada | 10 |
| London Health Sciences Centre | London | Canada | 58 |
| Ontario Shores Centre For Mental Health Sciences | Whitby | Canada | 7 |
| St. Michael's Hospital | Toronto | Canada | 16 |
| Sunnybrook Health Sciences Centre | Toronto | Canada | 167 |
| University of Calgary | Calgary | Canada | 15 |